NEW ORLEANS — With an international shortage of donor corneal tissue, a procedure that uses a patient’s own cells to repair the endothelium may be a viable alternative for transplantation, according to an expert here.
Deepinder K. Dhaliwal, MD, said at the Eyecelerator meeting that Fuchs’ endothelial corneal dystrophy, the most common kind of endothelial dysfunction, is typically treated with either descemetorhexis without endothelial keratoplasty or Descemet’s stripping automated endothelial keratoplasty.
“We strip away that endothelial diseased layer,” she